©2024 Stanford Medicine
Postoperative Pain Management in Rhinoplasty
Not Recruiting
Trial ID: NCT03584152
Purpose
The primary purpose of the study is to determine adequacy of postoperative pain control after
nasal surgery in patients prescribed Acetaminophen (325mg) + Hydrocodone (5mg) compared to
Acetaminophen(325mg) + Ibuprofen (200mg)for a period of 5 days after nasal surgery. To assess
the degree of pain, the participants will score the intensity of their pain on a visual
analog scale(VAS)of 0-100points (0- no pain and 100- most severe pain), preoperatively and
postoperatively (to be documented before each dose) for the duration of the prescribed
medications .
Additionally, the study will also seek to track:
1. The total number of pills each patients consume from the prescribed 5 day regimen.
2. Any associated side effects.
3. Additional pain medications prescribed in case of inadequate pain control,
postoperatively.
Official Title
Postoperative Pain Management in Rhinoplasty: A Randomized Controlled Trial
Stanford Investigator(s)
Sam P. Most, MD, FACS
Professor of Otolaryngology - Head & Neck Surgery (OHNS)
Eligibility
Inclusion Criteria:
- Minimum age of 18 years
- Able to speak and understand english.
- Undergoing rhinoplasty for cosmetic purposes
- Undergoing rhinoplasty for treatment of nasal obstruction
Exclusion Criteria:
- Less than 18 years of age
- Cannot speak and understand english
- Patients who have undergone nasal surgery in the past
- Patients not undergoing nasal surgery
- Women will be excluded if they are either pregnant or lactating as this population
does not undergo nasal surgery at our center.
- Patients with any known allergies to the class of pain medications used in the study.
Please note: Any person interested in this clinical trial should contact the Facial Plastic
and Reconstructive Surgery clinic at (650) 736 - FACE (3223) to schedule a consultation
with Dr. Sam P. Most to assess their eligibility for the trial. Please note, enrolling in
the clinical trial will not entitle the participant to a waiver of charges associated with
undergoing nasal surgery.
Intervention(s):
drug: Norco 5Mg-325Mg Tablet
drug: Tylenol 325Mg Caplet
drug: Ibuprofen 200 mg
Not Recruiting
Contact Information
Stanford University
School of Medicine
300 Pasteur Drive
Stanford,
CA
94305
Cherian K Kandathil, MD
650-721-6000